Flu shots are available in our local drugstores as we head into the fall and winter flu season. The flu vaccine must be made every year primarily because the hematagglutinin surface protein on the viral surface mutates. However some new information suggests that a more permanent flu vaccine could be used. In research trials a new "universal" vaccine was found to be effective against flu viruses go back to 1934!
In this blog answer the following questions:
1 Why do they use eggs to make the flu vaccine? Are there other ways to make flu vaccines?
2 A DNA vaccine is used to "prime" flu vaccines in research trials. How does this work?

Eggs are used to make the flu vaccine because they are a cheaper host to grow the virus in than living animals. In addition, eggs are easy to come by. Other ways to make flu vaccines include growing viruses in animal cell cultures and using DNA-based vaccinations. DNA vaccines administer the DNA encoding the protein antigen of the virus in a plasmid. When the body takes up the plasmid, the gene for the virus is eventually transcribed, degraded into peptides, and presented by the major compatibility complex. This induces a cellular and antibody response to the antigen.
ReplyDeleteDNA vaccines can also be used to "prime" flu vaccines by enhancing humoral and T-cell immune responses. Once the DNA is administered in a plasmid, as mentioned above, a live or non-replicating virus boost follows. This two-step approach causes the immune system to work even more effectively than both methods used separately.
Eggs are the less expensive host for a vaccination when compared with live animals. Also, it is far easier to get the antibodies from an egg than from the serum of a living animal.
ReplyDeleteThere are alternatives to egg derived antigens. One example is small doses of the flu that have been diluted and will stimulate the immune system with minimal consequences. These doses must be repeated to induce a proper immunization.
Eggs are used to manufacture the flu vaccine because they are relatively inexpensive and readily available for use. This is especially important considering it takes 6 months to prepare enough flu vaccine to vaccinate the entire population in case of a pandemic. The amniotic cavity of the eggs also provides a nutrient rich and sterile environment for the virus to replicate itself in.
ReplyDeleteFlu vaccines can also be manufactured by growing the virus in animal cell cultures in a sterile environment with ample nutrients. The drawback to this method is that the amount of virus produced is limited by the amount of animal cell culture obtained. Another method currently being considered is the construction of “influenza virus-like particles.” These particles are derived from insect cells that have been infected with baculovirus, which contain proteins similar to those found in the influenza virus. They draw out antibodies that respond to a far wider range of viral antigens, and thus hold promise for a universal influenza vaccine.
A DNA vaccine is used to prime flu vaccines in research trials by injecting test animals with a vaccine made from the DNA that codes for hemagglutinin (HA) surface protein of the influenza virus. After receiving this vaccine, test animals were given a dose of the seasonal flu vaccine, which also contains HA surface protein. The combination of these two vaccines stimulated an immune response to HA protein. While the head of HA regularly mutates, making a flu vaccine targeted at this surface protein difficult, the stem of the protein remains recognizable from strain to strain, allowing a vaccine directed at this portion of the protein to neutralize multiple strains of influenza.
ReplyDeleteA new vaccine is underway for the avian flu A virus. Epitopes for cytotoxic T lymphocytes are injected subcutaneously. These highly immunogenic epitopes are located on most viruses. Injecting mice with these epitope peptides led to survival against the avian flu A virus in subsequent phases. This is why this new vaccine appears to be so promising.
ReplyDeleteDNA vaccines can prime flu vaccines. This is because DNA vaccines are able to increase T-cell and Complement responses. DNA vaccines are a circular piece of bacterial DNA (called a plasmid) that has been genetically engineered to produce one or two specific proteins (antigens) from a pathogen. The vaccine DNA is injected into the cells of the body, where the "inner machinery" of the host cells "reads" the DNA and converts it into pathogenic proteins. Because these proteins are recognised as foreign, when they are processed by the host cells and displayed on their surface, the immune system is alerted, which then triggers a range of immune responses.
ReplyDeleteVaccines are made using chicken eggs because in order to replicate viruses you need living cells. Fertilized embryos are infected with the virus, which may then multiply. Large amounts of virus are needed to produce vaccines. The reason chicken eggs are used as opposed to other tissues is a a combination of two factors. The first being that the influenza virus effects chickens as well humans, hence the avian flu scare a few years back. This makes chickens ideal for producing the virus. The second is that chicken embryos are relatively cheap sources of biological tissue that can be used to multiply the virus, and the egg provides a convenient protective casing for the incubation.
ReplyDeleteThe reason why chicken eggs are used to produce flu vaccines is somewhat obvious: they're cheap, replaceable, easy to transport, easy to acquire, plus all the previous reasons stated (i.e. easy to work with). The problem with using chicken eggs though is that if the patient is allergic to eggs, there may be some negative reaction toward the vaccine besides the normal side effects. Although, there haven't been any documented cases of anyone having serious reactions to flu vaccines because of being allergic to chicken eggs.
ReplyDeleteThere are alternatives to using chicken eggs to make vaccines. One of them being insect cells. There have been some significant studies done on this and they seem promising.
source: http://www.urmc.rochester.edu/news/story/index.cfm?id=1431
DNA vaccines can be used to elicit specific T cell responses that are advantageous for efficient immunogenic response toward viral particles in the killed influenza vaccine. Patients are inoculated with plasmids containing viral DNA, which transcribes one or two antigens. These antigens then stimulate T cell response, which results in highly efficacious immunity. Subsequently, the immune system will respond more effectively to the killed virus vaccine, conferring stronger immunity to the virus.
ReplyDeleteThe DNA vaccine could be viewed as a form of adjuvant, administered prior to proper vaccination. The use of DNA vaccines shows future promise, in that it may be used in the future with live, attenuated viruses to confer broad-spectrum immunity to the ever-evolving influenza virus.
The use of DNA vaccines demonstrated greater efficacy than killed vaccines, and greater safety than live attenuated vaccines. Therefore it also shows promise as a third generation vaccine, in that it may completely replace the killed and live attenuated vaccines completely. The reason why this has not yet occurred, and they are used in conjunction with killed vaccines, is because the effectiveness of the DNA influenza vaccine has yet to be conclusively supported by current trials.
So as everyone has been saying… one of the reason eggs are used is because they are cheap and easy to come by. The good yield that scientist have been able to get has also led to its widespread use. However, there can be some problems with this method such as allergic reactions. Also, there may be cases of incompatibility with strains that affect birds like chickens.
ReplyDeleteAnother technique that has been under development is using insect cells instead of chicken eggs. Even though chicken eggs are cheap and easily accessible, they are still cumbersome to work with on a large scale. Also, it takes a good amount of time for the virus to grow correctly in the egg (about 6 months). However, the use of cell cultures to grow the viruses as shown positive results; its faster and more manageable. By using the cells, production of the vaccines could be reduced by one or two months. This technique would also be an advisable alternative if a bird flu pandemic hit hard.
ReplyDeleteTo make a DNA vaccine, RNA or DNA from the virus is extracted and its genetic sequence is generated from this. Based on the genetic sequence, primers are made and are used to generate cDNA which is inserted into a circular piece of DNA (plasmid). This plasmid is injected into the host being vaccinated where it is converted into antigens. Being antigens, they are seen as foreign and are presented by the host cells on the surface which elicits an immune response (T cell response).
ReplyDeleteThis kind of vaccination is called a third generation vaccination. First generation vaccines are vaccines made from attenuated live forms from whole organisms. However, there is a small risk involved in using these first gen vaccines since they can revert back to their dangerous/fatal forms. That, plus they can also prove a hazard for those who have weaker immune systems (like people with AIDS). Second generation vaccines are vaccines made from subunits. These vaccines were used specifically to address the risks involved in using first generation vaccines.
Why do they use eggs to make the flu vaccine? Are there other ways to make flu vaccines?
ReplyDeletewe use eggs because they are much less expensive than other tissues plus they are easy to use and easy to grow bacteria on and viruses on they also provide a limited area of substance that the bacteria can grow on, so they can be contained more effectively. Lastly there easily replaceable if messed up.
2 A DNA vaccine is used to "prime" flu vaccines in research trials. How does this work?
the DNA is used to "prime" so to speak because they excel hurmerol and t-cell response, also
DNA-based vaccines incorporate DNA coding for virus proteins, in a plasmid (small autonomous DNA sequences that are easily manipulated in the laboratory). The plasmid vaccine is introduced into the host where it produces the viral proteins (in the absence of intact virus) to which the host immune system raises an antibody and cell-based defense, thus priming the host for a subsequent attack. The experimental DNA influenza virus vaccine is based on sequences that do not readily mutate each season.
also DNA vaccine provided significantly better protection against several strains of influenza compared with current killed-virus vaccines. As expected, immunization with hemaglutination DNA alone was most effective when the immunogen exactly matched the challenge strain. A combination of HA DNA and internal protein DNA from various flu strains provided significant cross protection.
ReplyDeleteDNA vaccines offer a number of potential advantages over immunization with vaccines made from whole inactivated virus, subunit vaccines, or recombinant products. For example, the DNA vaccines have the potential to protect against different antigenic variants. Also, since DNA vaccines are derived directly from human specimens, problems with divergent mutants can be minimized. The DNA vaccines should also be easier to manufacture.
Another potential advantage of the DNA vaccine is that it may induce presentation of epitopes that more closely resemble those found in native flu virus compared with viral proteins produces in E.Coli, yeast or insect cells. DNA vaccines also do not require the use of formalin (used to inactivate whole virus) which may help preserve amino acid side chains in key epitopes.
source.
Henahan, Sean. "DNA PROVIDES BETTER FLU VACCINE." Access Excellence @ the National Health Museum. Web. 03 Oct. 2011. .